Hi all, I’ve been reading many posts on here learning so much to try to understand this disease and treatments. You all have my utmost respect for your courage, knowledge and kindness. So after fully recovering from RALP (all plumbing working with a little help from Cialis) my PSA has start to rise from undetectable (Full info in BIO) to currently at 0.14.
I will be participating in a Trial (code name Formula 509 at Dana Farber) starting Monday 6/10. ADT for 6 months consisting of Lupron + Zytiga (Abiraterone) w Prednazone + Etealda (Apalutamide). SRT starts in 6 weeks.
While I’m hopeful this aggressive treatment will successful, I’m concerned about the side effects by this combo of treatment. The literature is scary.
Any thought appreciated.
First, not every RO is convinced that ADT is needed at all with SRT when the PSA is below 0.5. But if you want an aggressive approach, It looks like a good trial:
clinicaltrials.gov/ct2/show...
But side effects are the price one pays for an aggressive approach. A recent trial combining Xtandi and Zytiga showed no extra benefit from the two agents but side effects were worse. Will Zytiga+Erleada+ADT work any better than ADT alone or without ADT at all?
Thanks for the response. That’s the question I guess 🙂. My PSA has been rising fast from what I can deduce. Concerned about that. My thought is that if I don’t benefit maybe someone else will.